High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (Q37163734)
Jump to navigation
Jump to search
scientific article published on 31 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses |
scientific article published on 31 August 2009 |
Statements
1 reference
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (English)
1 reference
Hagop M Kantarjian
1 reference
Jorge E Cortes
1 reference
Maher Albitar
1 reference
Francis J Giles
1 reference
Jerald Radich
1 reference
August Salvado
1 reference
Meir Wetzler
1 reference
Luke Akard
1 reference
Stuart L Goldberg
1 reference
Bayard L Powell
1 reference
John M Burke
1 reference
Robert Kerr
1 reference
Mansoor Saleh
1 reference
Karen McDougall
1 reference
Rationale and Insight for Gleevec High-Dose Therapy (RIGHT) Trial Study Group
1 reference
1 reference
1 reference
Identifiers
1 reference